Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2007-06-12
2007-06-12
Campell, Bruce R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
Reexamination Certificate
active
11241443
ABSTRACT:
The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of a biopolymer.
REFERENCES:
patent: 5062935 (1991-11-01), Schlag et al.
patent: 5538897 (1996-07-01), Yates et al.
patent: 6020208 (2000-02-01), Hutchens et al.
patent: 6194163 (2001-02-01), Doyle et al.
patent: 09121888 (1997-05-01), None
patent: WO90/14148 (1990-11-01), None
patent: WO93/24834 (1993-12-01), None
patent: WO98/07036 (1998-02-01), None
patent: WO00/49410 (2000-08-01), None
patent: WO01/05422 (2001-01-01), None
patent: WO01/14580 (2001-03-01), None
patent: WO01/21188 (2001-03-01), None
R. Richter et al, “Composition of the peptide fraction in human blood plasma: database of circulating human peptides”, Journal of Chromatography B, 726:25-35 (1999).
M. Takahashi et al, “Rapid and sensitive immunoassay for the measurement of serum S100B using isoform-specific monoclonal antibody”, Clinical Chemistry, 45(8):1307-1311 (1999).
M. Casl et al, “Serum amyloid A protein in patients with acute myocardial infarction”, Ann Clin Biochem, 32:196-200 (1995).
R. Christenson et al, “Biochemical markers of the acute coronary syndromes”, Clinical Chemistry, 44:8 (B):1855-1864 (1998).
D. Morrow et al, “Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy”, Journal of the American College of Cardiology, 35(2):358-362 (2000).
J. Danesh et al, “Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses”, British Medical Journal, 321(7255):199-204 (2000).
Jackowski George
Marshall John
Thatcher Brad
Vrees Tammy
Yantha Jason
Artemis Proteomics, Ltd.
Audet Maury
Campell Bruce R.
McHale & Slavin P.A.
LandOfFree
Biopolymer marker indicative of disease state having a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biopolymer marker indicative of disease state having a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biopolymer marker indicative of disease state having a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3836157